Hc and Restrictive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Restrictive pulmonary disease is reported as a side effect among people who take Hc (hydrocortisone), especially for people who are male, 60+ old, also take Ativan, and have Bone loss.

The phase IV clinical study analyzes which people have Restrictive pulmonary disease when taking Hc. It is created by eHealthMe based on reports of 1,263 people who have side effects when taking Hc from the FDA, and is updated regularly.

What is Hc?

Hc has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 1,369 Hc users. Check the latest studies of Hc.

What is Restrictive pulmonary disease?

Restrictive pulmonary disease (reduction in total lung capacity) is found to be associated with 300 drugs and 362 conditions by eHealthMe. Check the latest studies of Restrictive pulmonary disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

1,263 people reported to have side effects when taking Hc.
Among them, 12 people (0.95%) have Restrictive pulmonary disease.

Could Hc cause Restrictive pulmonary disease?

Among these 12 people:

What is the gender of people who have Restrictive pulmonary disease when taking Hc? *

female: 0.0 %
male: 100 %

What is the age of people who have Restrictive pulmonary disease when taking Hc? *

What are other drugs people take besides Hc? *

What are other side effects people have besides Restrictive pulmonary disease? *

Weakness: 12 people, 100.00%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 12 people, 100.00%
Gastroenteritis (inflammation of stomach and intestine): 12 people, 100.00%
Herpes Zoster: 12 people, 100.00%
High Blood Pressure: 12 people, 100.00%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 12 people, 100.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 100.00%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 12 people, 100.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 12 people, 100.00%
Fall: 12 people, 100.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 12 people, 100.00%
Bone Loss: 12 people, 100.00%
Sleep Disorder: 1 person, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 8.33%
Post-Traumatic Stress Disorder: 1 person, 8.33%
Panic Disorder: 1 person, 8.33%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 8.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 8.33%
Aplastic Anemia: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hc and have Restrictive pulmonary disease?

- Check whether Restrictive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hc:

Hc (1,369 reports)

Browse all side effects of Hc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (300 drugs)

Browse all the conditions that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone (the active ingredients of Hc) and Hc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.